2001
Double Digit Growth from Balanced Geographic Performance; Earnings Per Share Reach $0.40 Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in technology for the treatment...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today that it will host its annual analyst meeting...
Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, today announced that the company has...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, will conduct a live webcast of its third quarter 2001 earnings...
Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT) today announced the global launch of its second-generation VIATRAC(tm) 14 PLUS Peripheral Dilatation Catheter...
New Pacemaker Offers Advanced Therapy, Comprehensive Patient Management and Ease-of-Use Features Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...
Indianapolis, Ind. and Bloomington, Ind. - Guidant Corporation (NYSE and PCX: GDT) and COOK Incorporated today announced that an investigational device exemption (IDE) application has been...
Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced that Ralph Hall, currently secretary and general counsel, cardiac rhythm management, has been promoted...
Company Launches New Polymer Coated Guide Wire in the U.S. Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) a world leader in the treatment of coronary artery...
Guidant Completes ACTION Clinical Trial Enrollment for FDA Filing; Company Confirms Submission of PMA Amendment for Heart Failure Technology Guidant Completes ACTION Clinical Trial Enrollment for...
Several New Features Designed to Enhance Patient Management Indianapolis, IN and Tokyo, Japan - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and...
Patients Continue to Receive Medical Device Products on an Expedited Basis Indianapolis, Ind. - Ronald W. Dollens, president and CEO of Guidant Corporation (NYSE and PCX: GDT), expressing support...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) announced today that it has cancelled its briefing at the Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington,...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, will host a briefing at the Transcatheter Cardiovascular Therapeutics (TCT)...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) announced today that it has received European CE Mark approval of its next generation radiotherapy system. This...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) announced today that Nicky Spaulding has been promoted to the Guidant Management Committee as president of the...
Agreement Intended to Accelerate Time to Market and Complements Guidant's Drug-Coated Stent Program. Guidant Announces Live Webcast of its Drug-Coated Stent Briefing Indianapolis, Ind. - Guidant...
Less-Invasive Therapy Available to Treat Patients with Abdominal Aortic Aneurysms Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that Debra F. Minott, currently deputy general counsel and secretary, Guidant, has been promoted to vice president,...
Latest Stent Constructed of New Material Designed to Enhance Performance Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...
Indianapolis, Ind. - Guidant Corporation today stated that a recent U.S. Court of Appeals ruling on a coronary stent patent infringement suit affirms the strength of specific Guidant coronary...
New Product Introduction Broadens Guidant's Global Line of Non-Coronary Therapies Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT) today announced the global...
European Market Release of CONTAK RENEWAL, First Human Use Worldwide of CONTAK RENEWAL 2 Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced European market...
Earnings per share reach $0.38. Double-digit sales growth projected for the third and fourth quarters. Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in technology for...
Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it has received an...